Author: Sandip Pravin Patel
Publisher: Springer
ISBN: 3319637576
Category : Medical
Languages : en
Pages : 336
Book Description
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Early Phase Cancer Immunotherapy
Author: Sandip Pravin Patel
Publisher: Springer
ISBN: 3319637576
Category : Medical
Languages : en
Pages : 336
Book Description
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Publisher: Springer
ISBN: 3319637576
Category : Medical
Languages : en
Pages : 336
Book Description
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
National Library of Medicine Current Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1242
Book Description
First multi-year cumulation covers six years: 1965-70.
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1242
Book Description
First multi-year cumulation covers six years: 1965-70.
Oncology
The Unofficial Guide to Chicago
Author: David Hoekstra
Publisher: John Wiley & Sons
ISBN: 0470379995
Category : Travel
Languages : en
Pages : 386
Book Description
From the publishers of The Unofficial Guide to Walt Disney World "A Tourist's Best Friend!" —Chicago Sun-Times "Indispensable" —The New York Times The Top 10 Ways The Unofficial Guide to Chicago Can Help You Have the Perfect Trip: Information that's candid, critical, and totally objective Hotels reviewed and ranked for value and quality—plus secrets for getting the lowest possible rate More than 70 restaurants reviewed and profiled, with listings for dozens more A complete guide to Chicago's sights—museums, architecture, ethnic neighborhoods, and more Complete information on Chicago's lakefront beaches and parks The inside story on shopping—where to get the best for less, on and off the Magnificent Mile All the details on Chicago's nightlife—jazz and blues clubs, dance clubs, concerts, theater, and more The best places to play golf and tennis, ride a bike, go boating, and work out Tips on enjoying Chicago with your kids Advice on how to plan and make the most of your business trip Get the unbiased truth on hundreds of hotels, restaurants, attractions, and more in The Unofficial Guide to Chicago—the resource that helps you save money, save time, and make your trip the best it can be.
Publisher: John Wiley & Sons
ISBN: 0470379995
Category : Travel
Languages : en
Pages : 386
Book Description
From the publishers of The Unofficial Guide to Walt Disney World "A Tourist's Best Friend!" —Chicago Sun-Times "Indispensable" —The New York Times The Top 10 Ways The Unofficial Guide to Chicago Can Help You Have the Perfect Trip: Information that's candid, critical, and totally objective Hotels reviewed and ranked for value and quality—plus secrets for getting the lowest possible rate More than 70 restaurants reviewed and profiled, with listings for dozens more A complete guide to Chicago's sights—museums, architecture, ethnic neighborhoods, and more Complete information on Chicago's lakefront beaches and parks The inside story on shopping—where to get the best for less, on and off the Magnificent Mile All the details on Chicago's nightlife—jazz and blues clubs, dance clubs, concerts, theater, and more The best places to play golf and tennis, ride a bike, go boating, and work out Tips on enjoying Chicago with your kids Advice on how to plan and make the most of your business trip Get the unbiased truth on hundreds of hotels, restaurants, attractions, and more in The Unofficial Guide to Chicago—the resource that helps you save money, save time, and make your trip the best it can be.
国立国会図書館所蔵科学技術関係欧文会議錄目錄
Author: 国立国会図書館 (Japan)
Publisher:
ISBN:
Category : Science
Languages : en
Pages : 1762
Book Description
Publisher:
ISBN:
Category : Science
Languages : en
Pages : 1762
Book Description
Journal of the National Cancer Institute
National Library of Medicine Audiovisuals Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Health education
Languages : en
Pages : 724
Book Description
Publisher:
ISBN:
Category : Health education
Languages : en
Pages : 724
Book Description
Monoclonal Antibodies: Advances in Research and Application: 2011 Edition
Author:
Publisher: ScholarlyEditions
ISBN: 1464928436
Category : Medical
Languages : en
Pages : 135
Book Description
Monoclonal Antibodies: Advances in Research and Application: 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Monoclonal Antibodies. The editors have built Monoclonal Antibodies: Advances in Research and Application: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Monoclonal Antibodies in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Monoclonal Antibodies: Advances in Research and Application: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Publisher: ScholarlyEditions
ISBN: 1464928436
Category : Medical
Languages : en
Pages : 135
Book Description
Monoclonal Antibodies: Advances in Research and Application: 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Monoclonal Antibodies. The editors have built Monoclonal Antibodies: Advances in Research and Application: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Monoclonal Antibodies in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Monoclonal Antibodies: Advances in Research and Application: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Meetings on Atomic Energy
For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug
Author: Nathan Vardi
Publisher: W. W. Norton & Company
ISBN: 0393540960
Category : Business & Economics
Languages : en
Pages : 254
Book Description
A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market—and save countless lives. For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how members of the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time. In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks—and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they’re onto something big. What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi’s narrative immerses readers in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction read, For Blood and Money illustrates why it’s so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine.
Publisher: W. W. Norton & Company
ISBN: 0393540960
Category : Business & Economics
Languages : en
Pages : 254
Book Description
A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market—and save countless lives. For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how members of the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time. In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks—and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they’re onto something big. What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi’s narrative immerses readers in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction read, For Blood and Money illustrates why it’s so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine.